Document Detail


Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease.
MedLine Citation:
PMID:  15605069     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Infants with neonatal herpes, classified as central nervous system or disseminated disease, have a high incidence of moderate and severe neurologic deficits despite standard acute therapy. STUDY DESIGN: Following completion of parenteral therapy, infants with central nervous system and/or disseminated disease received 2 years of continuous oral acyclovir therapy. Target minimum peak serum acyclovir concentrations were >2 microg/ml for the first three patients, and >3 microg/ml for the subsequent 13 patients. Safety assessments were made every 3 months. We evaluated neurodevelopmental outcomes with Bayley Scales of Infant Development. RESULTS: A total of 16 consecutive herpes simplex virus-infected infants born during 1990 to 2003 received the treatment plan; 13/16 infants had central nervous system disease; 3 had disseminated disease without central nervous system involvement. A total of 69% (11/16) had Bayley scores in the normal range for mental development and 79% (11/14) had motor scores in the normal range. At the final assessment, five children had developmental delays. One child had severe mental delay with normal motor development. Four children had mild mental delays, with severe motor delays in three. All children were independently mobile, without seizure disorder, had normal vision, and had speech development. During the 2-year course of treatment, five children had brief recurrences of dermal lesions, and none had evidence of neurologic deterioration. There were no serious or sustained adverse drug reactions. CONCLUSION: This pilot study reports improved outcomes in a small cohort of infants with a prolonged course of oral acyclovir. A minority of these children exhibited mild or significant developmental delays. Further investigation of this approach to treatment is warranted.
Authors:
K F Tiffany; D K Benjamin; P Palasanthiran; K O'Donnell; L T Gutman
Related Documents :
1538279 - Effects of early intervention on cognitive function of low birth weight preterm infants.
15673649 - A reliable pain assessment tool for clinical assessment in the neonatal intensive care ...
15725359 - Does angiotensin-1 converting enzyme genotype influence motor or cognitive development ...
12029449 - Serial bronchoalveolar lavage of preterm infants is not associated with chest radiologi...
10584469 - Acquired microcephaly after low apgar score in zimbabwe.
16001919 - Multisite study of infants with single-suture craniosynostosis: preliminary report of p...
3753649 - Low protein c in the neonatal period.
16570669 - Neonatal lupus erythematosus.
16765489 - Increased murine neonatal iron intake results in parkinson-like neurodegeneration with ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  25     ISSN:  0743-8346     ISO Abbreviation:  J Perinatol     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-25     Completed Date:  2005-06-21     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  156-61     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Duke University, Durham, NC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acyclovir / administration & dosage*,  blood
Administration, Oral
Brain / growth & development*
Brain Diseases / drug therapy,  physiopathology
Child Development / physiology
Child, Preschool
Developmental Disabilities / etiology
Herpes Simplex / complications,  drug therapy*,  physiopathology
Humans
Infant
Infant, Newborn
Pilot Projects
Treatment Outcome
Grant Support
ID/Acronym/Agency:
HD-03-001/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
59277-89-3/Acyclovir
Comments/Corrections
Comment In:
J Perinatol. 2005 Mar;25(3):154-5   [PMID:  15731744 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human breast milk and xenoestrogen exposure: a possible impact on human health.
Next Document:  One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective st...